Adrixetinib TFA
Adrixetinib (TFA) is a small molecule tyrosine kinase inhibitor with antineoplastic activity, primarily targeting receptors such as MET and VEGFR2. It is applied in oncology research for studying tumor growth and angiogenesis, utilizing both in vitro kinase assays and in vivo xenograft models.
Product Specifications
Field of Research
Immunology & Inflammation, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7169973 Inquire
Rabbit anti-Escherichia coli O9:H4 (strain HS) RLMH Polyclonal Antibody
Sign In for Pricing
View Details K0898804 1.0 µg DNA
GPR160 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details